General information

Announcements(0)

Program

Sessions

Search presentations

Download PDF for print

en.png

icon_20251202233619897.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

Abstract password authentication.<br>A password is required to view the full text of the abstract. Please enter the following password.<br><br>PW: Neuro2024

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Announcements

Profile management

Bookmark

Timetable

Now what is required for the treatment of depression: the probability of vortioxetine

Co-sponsored by Takeda Pharmaceutical Company Limited/Lundbeck Japan K.K.

NEURO2024

Presentation Information

[2LS-05]Now what is required for the treatment of depression: the probability of vortioxetine